You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

surrogate endpoint

Showing 1 - 25 of 5,673
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Measurable Residual Disease in Acute Myeloid Leukemia as

Terminated
  • Leukemia, Myeloid, Acute
  • Measurable residual disease measured by flow cytometry
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Sep 12, 2022

Laser Doppler Flowmetry to Identify Allergic Rhinitis

Active, not recruiting
  • Allergic Rhinitis
    • Kansas City, Missouri
      Children's Mercy Hospital
    Mar 2, 2022

    Waldenstrom's Disease, Prognostic Index Trial in France

    Not yet recruiting
    • Waldenstrom's Disease
    • Prognostic Index
      • Amiens, France
      • +14 more
      Jun 12, 2023

      Chronic Kidney Diseases Trial (Dapagliflozin)

      Not yet recruiting
      • Chronic Kidney Diseases
      • (no location specified)
      Jan 18, 2022

      Prediction of Neuropathy in Type 1 Diabetes

      Completed
      • Diabetic Polyneuropathy
      • +4 more
      • Exposure: Corneal nerve fibre morphology by the CCM Procedure
      • Ann Arbor, Michigan
      • +4 more
      Nov 4, 2019

      Heart Failure With Reduced Ejection Fraction Trial in Badalona, Sevilla, Valencia (Evolocumab)

      Completed
      • Heart Failure With Reduced Ejection Fraction
      • Badalona, Barcelona, Spain
      • +2 more
      Aug 10, 2022

      Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60

      Active, not recruiting
      • Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
      • epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
      • +5 more
      • Candiolo, TO, Italy
      • +14 more
      Nov 15, 2021

      Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • +2 more
      • The Cleerly CAD Staging System
      • (no location specified)
      Oct 31, 2023

      Contraception Trial in Norfolk (ZB-06)

      Completed
      • Contraception
      • ZB-06
      • Norfolk, Virginia
        Eastern Virginia Medical School
      Jun 15, 2022

      Kidney Tumor Trial (partial kidney nephrectomy, DaVinci Robot, Innersight 3D software)

      Not yet recruiting
      • Kidney Tumor
      • partial kidney nephrectomy
      • +2 more
      • (no location specified)
      Sep 29, 2023

      Asthma Trial in Worldwide (AZD4604, Placebo)

      Not yet recruiting
      • Asthma
      • Stockton, California
      • +24 more
      Aug 25, 2023

      Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial Neoplasia 2

      Recruiting
      • Cervical Intraepithelial Neoplasia
      • +2 more
      • Pembrolizumab
      • Los Angeles, California
        University of California at Los Angeles / Jonsson Comprehensive
      Jan 20, 2022

      Delayed SLND for Breast Cancer Undergoing Primary Systemic

      Active, not recruiting
      • Breast Cancer
      • +2 more
      • SLND or TAD by the magnetic technique (SPIO)
      • Uppsala, Sweden
        Uppsala University Hospital
      Aug 2, 2023

      Breast Cancer Trial in United States (tamoxifen citrate)

      Terminated
      • Breast Cancer
      • tamoxifen citrate
      • Oklahoma City, Oklahoma
      • +3 more
      Jan 22, 2019

      Chronic Wounds, Acute Wounds Trial in Pittsburgh (AnaSept®, NSS)

      Completed
      • Chronic Wounds
      • Acute Wounds
      • AnaSept®
      • NSS
      • Pittsburgh, Pennsylvania
        Serena Group Research Institute
      Mar 11, 2022

      Breast Cancer, Triple Negative Breast Cancer, Luminal B Trial in Belgium (Paclitaxel, Epirubicin, Cyclophosphamide)

      Active, not recruiting
      • Breast Cancer
      • +2 more
      • Charleroi, Hainaut, Belgium
      • +3 more
      Aug 2, 2022

      Bladder Cancer Trial in Rome (Open or robotic radical cystectomy)

      Active, not recruiting
      • Bladder Cancer
      • Open or robotic radical cystectomy
      • Rome, Lazio, Italy
        Regina Elena NCI
      Apr 28, 2022

      Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

      Not yet recruiting
      • Early-stage Breast Cancer
      • Atezolizumab 1200 mg in 20 ML Injection
      • +5 more
      • Heidelberg, Baden-Wuerttemberg, Germany
        National Center for Tumor Diseases
      Sep 13, 2022

      Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal

      Recruiting
      • Fabry Disease
        • Minneapolis, Minnesota
        • +1 more
        Sep 16, 2022

        Ventricular Tachycardia, Ischemic Cardiomyopathy Trial in Ann Arbor, Cleveland, Charleston (Ablation-index guided ventricular

        Not yet recruiting
        • Ventricular Tachycardia
        • Ischemic Cardiomyopathy
        • Ablation-index guided ventricular tachycardia ablation
        • Ventricular tachycardia ablation with no AI-guidance
        • Ann Arbor, Michigan
        • +2 more
        Nov 17, 2023

        Apical Periodontitis and Atherosclerotic Cardiovascular Diseases

        Recruiting
        • Apical Periodontitis
        • Atherosclerotic Cardiovascular Disease
        • Echo-color-doppler
        • Siena, Italy
          Azienda Ospedaliera Universitaria Senese
        Mar 19, 2023

        Histamine Biotransformation Trial in Kansas City (validated techniques for histamine response, new technique for histamine

        Withdrawn
        • Histamine Biotransformation
        • validated techniques for histamine response
        • new technique for histamine response
        • Kansas City, Missouri
          Children's Mercy Hospitals and Clinics
        Jan 5, 2021

        Cardiovascular Risk Factor Trial in Palermo (low fat, mediterranean diet)

        Completed
        • Cardiovascular Risk Factor
        • low fat
        • mediterranean diet
        • Palermo, Italy
          University of Palermo
        Apr 29, 2021

        NSCLC Trial in Philadelphia (device, drug, other)

        Not yet recruiting
        • NSCLC
        • Aliya Pulsed Electric Fields (PEF) ablation
        • +3 more
        • Philadelphia, Pennsylvania
          Temple University
        Oct 24, 2022

        Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

        Active, not recruiting
        • Bone Diseases
        • Pain
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 17, 2022